{"id":55380,"date":"2023-03-30T21:03:20","date_gmt":"2023-03-30T19:03:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/"},"modified":"2023-03-30T21:03:20","modified_gmt":"2023-03-30T19:03:20","slug":"correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/","title":{"rendered":"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice"},"content":{"rendered":"
\n

VANCOUVER, British Columbia–(BUSINESS WIRE)–#education<\/a>–Please replace the release with the following corrected version due to multiple revisions.\n<\/p>\n

<\/a><\/p>\n

\nThe updated release reads:\n<\/p>\n

\nREVITALIST ENTERS INTO NETWORK AGREEMENT FOR SPECIALTY PROVIDERS WITH CORECHOICE<\/b>\n<\/p>\n

\n(CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CoreChoice has entered into a agreement with Revitalis to participate in their Behavioral Health Network. This relationship will allow Revitalist to access many more patients to extend care for Behavioral Health. Furthermore, Revitalist is also pleased in announce a new COO Paul Auchterlonie.\n<\/p>\n

\nPaul Auchterlonie brings three decades of experience in C-Suite leadership focused primarily in behavioral health. Mr. Auchterlonie earned his Master\u2019s degree in adolescent development and administration from Harvard University. Additional skillsets include developing and implementing clinical solutions, technology oriented service models, admissions and marketing, disrupting fragmented services and verticals, building and improving company cultures, and leading entities towards value creation for all stakeholders. One of Mr. Auchterlonie\u2019s passions is helping the adolescent population who is struggling immensely with mental health concerns, and exponential increase of suicides.\n<\/p>\n

\n\u201cThe vision that CEO, Kathryn Walker, has for this company is strategically aligned for every demand of the current mental health system. This model will be a global model that will be able to directly address the concerns that continue to plague the current mental health system. The agreement that we have entered into with CoreChoice is just the beginning to the payment restructuring that we will be actively addressing in 2023,\u201d states Paul Auchterlonie.\n<\/p>\n

\nAbout Revitalist Lifestyle and Wellness, Ltd.<\/b>\n<\/p>\n

\nRevitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is a mental health and wellness company focused on comprehensive care in the ketamine wellness space offering innovative, evidenced based services. With physical locations and virtual offices across 28 states, Revitalist is one of the largest publicly traded psychedelic wellness companies in Northern America.\n<\/p>\n

\nAbout CoreChoice<\/b>\n<\/p>\n

\nCoreChoice, Inc. a specialty PPO Network for radiology, interventional pain management, and behavioral health management. It is customized for each client\u2019s needs. CoreChoice services the commercial group health, workers\u2019 compensation, and auto liability insurance sectors. In this model, CoreChoice works with clients to develop a specific network within a given city\/state\/region to service a carrier or employer group for the purpose of providing direct access care and at a very competitive price. More information is available at www.corechoice.net<\/a>\n<\/p>\n

\nOn Behalf of the Board\n<\/p>\n

\nKathryn Walker
\n
Chief Executive Officer\n<\/p>\n

\nTwitter: @RevitalistCorp
\n
Facebook: @RevitalistLifestyleandWellnessLtd.<\/a>
Instagram: @RevitalistCorp<\/a>
LinkedIn: @RevitalistLifestyleAndWellnessLtd<\/a>\n<\/p>\n

\nForward Looking Statements<\/i><\/b>\n<\/p>\n

\nThis news release contains forward-looking statements and information within the meaning of applicable securities legislation. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance of achievements expressed or implied by the forward-looking statements or information contained in this news release.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information:
\n
Revitalist Lifestyle and Wellness Ltd.
\n
Email: Corporate@Revitalist.com<\/a>
Tel: (865) 585-8414\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: REVITALIST ENTERS INTO NETWORK AGREEMENT FOR SPECIALTY PROVIDERS WITH CORECHOICE (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CoreChoice has entered into a agreement with Revitalis to participate in their Behavioral Health Network. This relationship will allow … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55380","6":"format-standard","7":"category-industry"},"yoast_head":"\nCORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: REVITALIST ENTERS INTO NETWORK AGREEMENT FOR SPECIALTY PROVIDERS WITH CORECHOICE (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CoreChoice has entered into a agreement with Revitalis to participate in their Behavioral Health Network. This relationship will allow ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-30T19:03:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230330005303\/en\/1751761\/21\/Revitalist_LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice\",\"datePublished\":\"2023-03-30T19:03:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/\"},\"wordCount\":503,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005303\\\/en\\\/1751761\\\/21\\\/Revitalist_LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/\",\"name\":\"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005303\\\/en\\\/1751761\\\/21\\\/Revitalist_LOGO.jpg\",\"datePublished\":\"2023-03-30T19:03:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005303\\\/en\\\/1751761\\\/21\\\/Revitalist_LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005303\\\/en\\\/1751761\\\/21\\\/Revitalist_LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/","og_locale":"en_US","og_type":"article","og_title":"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice - Pharma Trend","og_description":"VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: REVITALIST ENTERS INTO NETWORK AGREEMENT FOR SPECIALTY PROVIDERS WITH CORECHOICE (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CoreChoice has entered into a agreement with Revitalis to participate in their Behavioral Health Network. This relationship will allow ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-30T19:03:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230330005303\/en\/1751761\/21\/Revitalist_LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice","datePublished":"2023-03-30T19:03:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/"},"wordCount":503,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230330005303\/en\/1751761\/21\/Revitalist_LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/","url":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/","name":"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230330005303\/en\/1751761\/21\/Revitalist_LOGO.jpg","datePublished":"2023-03-30T19:03:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230330005303\/en\/1751761\/21\/Revitalist_LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230330005303\/en\/1751761\/21\/Revitalist_LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/correcting-and-replacing-revitalist-enters-into-network-agreement-for-specialty-providers-with-corechoice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CORRECTING and REPLACING\u00a0Revitalist Enters into Network Agreement for Specialty Providers with CoreChoice"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55380"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55380\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}